Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast Cancer
Conditions: Hormone-receptor-positive Breast Cancer; HER2-low Breast Cancer; HER2-negative Breast Cancer Intervention: Other: No drug Sponsor: Daiichi Sankyo, Inc. Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials